Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 47, Number 8, September 2007

< previous issue | all issues | next issue >

In This Issue
pp. 1115-1116(2)

From the Editorial Office
pp. 1117-1117(1)

Prognostic Significance of Personality Profiles in Patients With Chronic Migraine
pp. 1118-1124(7)
Authors: Luconi, Roberta; Bartolini, Marco; Taffi, Ruja; Vignini, Arianna; Mazzanti, Laura; Provinciali, Leandro; Silvestrini, Mauro

Less Is Not More: Underutilization of Headache Medications in a University Hospital Emergency Department
pp. 1125-1133(9)
Authors: Gupta, Madhavi X.; Silberstein, Stephen D.; Young, William B.; Hopkins, Mary; Lopez, Bernard L.; Samsa, Gregory P.

ED Treatment of Migraine Headache: Factors Influencing Pharmacotherapeutic Choices
pp. 1134-1143(10)
Authors: Hurtado, Timothy R.; Vinson, David R.; Vandenberg, J. Toby

Patient Preference for Triptan Formulations: A Prospective Study With Zolmitriptan
pp. 1144-1151(8)
Authors: Dowson, Andrew; Bundy, Michael; Salt, Rebecca; Kilminster, Shaun

Marketed Oral Triptans in the Acute Treatment of Migraine: A Systematic Review on Efficacy and Tolerability
pp. 1152-1168(17)
Authors: Pascual, Julio; Mateos, Valentin; Roig, Carles; Sanchez-del-Rio, Margarita; Jiménez, Dolores

Behavioral Sleep Modification May Revert Transformed Migraine to Episodic Migraine
pp. 1178-1183(6)
Authors: Calhoun, Anne H.; Ford, Sutapa

Insomnia and Circadian Variation of Attacks in Episodic Migraine
pp. 1184-1188(5)
Authors: Alstadhaug, Karl; Salvesen, Rolf; Bekkelund, Svein

Primary Headache and Sleep Disturbances in Adolescents
pp. 1189-1194(6)
Authors: Gilman, Deborah K.; Palermo, Tonya M.; Kabbouche, Marielle A.; Hershey, Andrew D.; Powers PhD ABPP, Scott W.

Association Between Migraine and the G1246A Polymorphism in the Hypocretin Receptor 2 Gene
pp. 1195-1199(5)
Authors: Schürks, Markus; Limmroth, Volker; Geissler, Ingrid; Tessmann, Grietje; Savidou, Irini; Engelbergs, Jörg; Kurth, Tobias; Diener, Hans-Christoph; Rosskopf, Dieter

Efficacy of Duloxetine as a Migraine Preventive Medication: Possible Predictors of Response in a Retrospective Chart Review
pp. 1200-1203(4)
Authors: Taylor, Anne P.; Adelman, James U.; Freeman, Marshall C.

Eye Pain Without Visual Symptoms
pp. 1206-1209(4)
Authors: Evans, Randolph W.; Foroozan, Rod

Familial Hemiplegic Migraine: Permanent Attack-Related Neurologic Deficits
pp. 1210-1212(3)
Authors: Dodick, David; Roarke, Michael

Tongue Necrosis in Temporal Arteritis
pp. 1213-1215(3)
Authors: Goicochea, Maria; Correale, Jorge; Bonamico, Lucfas; Dominguez, Raúl; Bagg, Eleonora; Famulari, Arturo; Ameriso, Sebastián; Sevlever, Gustavo

Positron Emission Tomography in the Diagnosis and Management of Giant Cell Arteritis
pp. 1216-1219(4)
Authors: Szmodis, Michael L.; Reba, Richard C.; Earl-Graef, David

Migraine and Cephalic Cutaneous Allodynia in Pediatric Patients
pp. 1219-1223(5)
Authors: Eidlitz-Markus, Tal; Shuper, Avinoam; Gorali, Olga; Zeharia, Avi

Headache Medicine-A Response
pp. 1225-1227(3)

Efficacy of Frovatriptan
pp. 1227-1227(1)

Harry Potter Writes
pp. 1230-1231(2)

Lagniappe
pp. 1232-1233(2)

Abstracts and Citations
pp. 1234-1244(11)
Authors: Tepper, Stewart J.; Stillman, Mark; Taylor, Frederick R.

Resident and Fellow Section
pp. 1245-1247(3)
Author: Levin, Morris

Chronic Pain and Migraine
pp. 1259-1261(3)

Is There Hope for Chronic Pain and Headache?
pp. 1262-1271(10)
Authors: Romero-Reyes, Marcela; Graff-Radford, Steven

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page